Tag Archives: NYSE: SNY

Sanofi announces it has successfully priced its €1 billion bonds due 2023 at 2.50%

Posted on 12, November 2013 by

Paris, France, 12-11-2013 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) announces that it has successfully priced its offering of EUR 1 billion of notes, due 2023, bearing interest at an annual rate of 2.50%. The issue is drawn under the Company’s Euro … Read the full press release →

Posted in Business, Financial, France, Healthcare, Investment, Pharma & Biotech, Science

Tagged , , , , , , , , , ,

U.S. FDA’s Nonprescription Drugs Advisory Committee recommends approval of Sanofi’s Nasacort AQ Nasal Spray for over-the-counter use in the U.S.

Posted on 6, August 2013 by

Treats Seasonal and Year-round Nasal Allergy Symptoms in Adults and Children  Paris, France, 06-8-2013 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration’s (FDA) Nonprescription Drugs Advisory Committee (NDAC) voted 10 to … Read the full press release →

Posted in Business, France, Government, Healthcare, Pharma & Biotech, Science

Tagged , , , , , , , , , , , , , , , , , , , , , , , ,